These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21519231)

  • 1. Serial urological interventions including circumcision in a hemophilic child with inhibitors.
    Leblebisatan G; Saşmaz I; Antmen B; Klnç Y; Aridoğan IA
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):547-8. PubMed ID: 21519231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumcision and complications in patients with haemophilia in southern part of Turkey: Çukurova experience.
    Sasmaz I; Antmen B; Leblebisatan G; Şahin Karagün B; Kilinç Y; Tuncer R
    Haemophilia; 2012 May; 18(3):426-30. PubMed ID: 22176339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.
    Parmar N; Berry LR; Paredes N; Chan AK
    Clin Lab; 2005; 51(3-4):157-66. PubMed ID: 15819171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboelastography in children with coagulation factor deficiencies.
    Chitlur M; Warrier I; Rajpurkar M; Hollon W; Llanto L; Wiseman C; Lusher JM
    Br J Haematol; 2008 Jun; 142(2):250-6. PubMed ID: 18492116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single centre experience in circumcision of haemophilia patients: Izmir protocol.
    Yilmaz D; Akin M; Ay Y; Balkan C; Celik A; Ergün O; Kavakli K
    Haemophilia; 2010 Nov; 16(6):888-91. PubMed ID: 20491959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circumcision in Hemophilia: A Multicenter Experience.
    Bawazir OA; Alharbi I
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e33-e36. PubMed ID: 33003145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumcision in hemophilia: the use of fibrin glue for local hemostasis.
    Martinowitz U; Varon D; Jonas P; Bar-Maor A; Brenner B; Leibovitch I; Heim M
    J Urol; 1992 Sep; 148(3):855-7. PubMed ID: 1512839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin glue, hemophilia, and circumcision in low-income countries.
    Tazi I
    J Pediatr Surg; 2011 Feb; 46(2):428-9. PubMed ID: 21292105
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
    Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass surgery in a patient with Haemophilia A: a case report.
    Menard CE; Zawadski D; Singal RK; Rimmer E; Houston DS; Houston BL; Zarychanski R
    Haemophilia; 2016 Jan; 22(1):e76-9. PubMed ID: 26635300
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary surgery in a hemophiliac with continuous factor VIII replacement.
    Kypson AP; Rodriguez E; Anderson CA
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):191-2. PubMed ID: 22499969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumcision, hemophilia, and being healthy in developing countries.
    Kavakli K; Nişli G
    Pediatr Hematol Oncol; 2001 Sep; 18(6):419-20. PubMed ID: 11554238
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of bleeding in hemophilia patients with high-titer inhibitors.
    Leissinger CA; Konkle BA; Antunes SV
    Expert Rev Hematol; 2015 Jun; 8(3):375-82. PubMed ID: 25937074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovations in coagulation: improved options for treatment of hemophilia A and B.
    Pabinger-Fasching I; Pipe S
    Thromb Res; 2013 Mar; 131 Suppl 2():S1. PubMed ID: 23537720
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of bypass surgery on coagulation-sensitive clotting factors.
    Woods JE; Kirklin JW; Owen CA; Thompson JH; Taswell HF
    Mayo Clin Proc; 1967 Nov; 42(11):724-35. PubMed ID: 6053800
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of the lymphocyte in antihemophilic globulin production: a rise in antihemophilic globulin levels in a hemophilic subject with acute lymphoblastic leukemia.
    Bouhasin JD; Monteleone P; Altay C
    J Lab Clin Med; 1971 Jul; 78(1):122-9. PubMed ID: 5285069
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitors in mild/moderate haemophilia A: an update.
    Franchini M; Salvagno GL; Lippi G
    Thromb Haemost; 2006 Aug; 96(2):113-8. PubMed ID: 16894451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.